{"disease":{"id":"immune-mediated-diseases","name":"immune mediated diseases"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04864886","title":"Metabolic Profiling of Immune Responses in Immune-mediated Diseases","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT06753942","title":"ANTI-SARS-CoV-2 SEROCONVERSIO IN IMMUNE-MEDIATED KIDNEY DISEASES","phase":"","overall_status":"COMPLETED","enrollment_count":120,"lead_sponsor_name":"IRCCS Azienda Ospedaliero-Universitaria di Bologna","has_results":false},{"nct_id":"NCT07033663","title":"Impact of In Utero Exposure to Immunomodulatory Drugs on Neonatal Immune System Development","phase":"","overall_status":"RECRUITING","enrollment_count":90,"lead_sponsor_name":"Fundació Sant Joan de Déu","has_results":false},{"nct_id":"NCT04446000","title":"Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneous CSL730 in Healthy Adult Subjects","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":52,"lead_sponsor_name":"CSL Behring","has_results":false},{"nct_id":"NCT05003089","title":"A Trial to Learn How BAY1834845 and BAY1830839 Affect Inflammation When Taken by Mouth Twice a Day for 7 Days in a Row in Healthy Male Participants","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":51,"lead_sponsor_name":"Bayer","has_results":false}],"total":5},"guidelines":[],"source":"Drug Landscape verified database"}